跳至主要内容
临床试验/NCT04578275
NCT04578275已完成不适用

STRATIFY TRIAL: Atrial Fibrillation Stratification Based on the Arrhythmia Perpetuation Mechanisms.

Felipe Atienza1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2018年4月18日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
200
试验地点
1
主要终点
ECGI calculation of frecuency maps(Hz)

研究概览

简要总结

Atrial fibrillation treatments have a limited efficacy and often cause long-term side effects. This study aims to develop and validate an ECGI system to risk stratification in patients with persistent AF, identifying the mechanisms responsible for the maintenance and the best treatment for ending it.

详细描述

The MAIN GOAL of this project is to clinically validate the technology for the noninvasive identification of the mechanisms responsible for maintenance of AF using ECGI. To achieve this goal, the investigators will analyze the efficacy of different treatment options in persistent AF patients as a function of the results of the ECGI. Mainly, patients will be evaluated attending to the complexity of the patterns obtained. Moreover, the investigators will evaluate the treatment benefit of performing guided-ablation in conjunction with pulmonary vein isolation as compared to pulmonary vein isolation only. These analyses will be performed in patients with persistent AF arriving at the clinic to determine treatment options. AF outcomes following the treatment assigned therapy will be evaluated at 6 months and 1 year after.

These parameters are obtained from the ECGI map: histogram of rotors (number of rotors and location), Highest and Lowest Dominant Frequency (Hz), rotor duration (ms), simultaneous rotors (number of rotors) and signal entropy (normalized).

Wide antrum circumferential pulmonary vein isolation with demonstration of bidirectional block will be performed using standard cooled-tip radiofrequency catheters or cryoballoon catheters.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with paroxysmal AF symptomatic and refractory to at least one antiarrhythmic medication arriving in atrial fibrillation to the AF clinic.
  • Patients with paroxysmal AF undergoing AF ablation in whom AF was induced at the EP laboratory.
  • Patients with persistent AF or long-term persistent AF attending the AF clinic.
  • Patients must be able and willing to provide written informed consent to participate in the study.
  • Prior anticoagulation for> 4 weeks or transesophageal echocardiogram excluding intracardiac thrombi.

排除标准

  • Inclusion Criteria:
  • Patients with paroxysmal AF symptomatic and refractory to at least one antiarrhythmic medication arriving in atrial fibrillation to the AF clinic.
  • Patients with paroxysmal AF undergoing AF ablation in whom AF was induced at the EP laboratory.
  • Patients with persistent AF or long-term persistent AF attending the AF clinic.
  • Patients must be able and willing to provide written informed consent to participate in the study.
  • Prior anticoagulation for> 4 weeks or transesophageal echocardiogram excluding intracardiac thrombi.
  • Exclusion Criteria:
  • Patients with inadequate anticoagulation levels, left atrial thrombus, tumor, or another abnormality which precludes catheter introduction on TEE prior to the procedure.
  • Patients with moderate-to-severe mitral regurgitation.
  • Patients with contraindications to systemic anticoagulation with heparin or coumadin.
  • Patients who are or may potentially be pregnant.
  • Current enrollment in another investigational drug or device study.
  • Pacemaker or Implantable Cardioverter Defibrillator.

结局指标

主要结局

ECGI calculation of frecuency maps(Hz)

时间窗: 12 months post-first intervention

Freedom from atrial fibrillation treated according to the ESC/AHA Atrial Fibrillation Guidelines in relation to the ECGI AF complexity score

ECGI calculation of frecuency of rotor maps

时间窗: 12 months post-first intervention

number of rotors mesasured Atrial Fibrillation Guidelines in relation to the ECGI AF complexity score

ECGI AF complexity score calculated from the results of 1 and 2 to evaluate AF freedom from atrial fibrilation

时间窗: 12 months post-first intervention

score calculated from the results of 1 and 2 to evaluate AF freedom from atrial fibrilation Atrial Fibrillation Guidelines in relation to the ECGI AF complexity score

次要结局

  • ECGI calculations of Highest Dominant Frecuency(Hz)(during ablation procedure and 12 months after)
  • Ablation procedure duration(Duration of ablation procedure)
  • Fluoroscopy time(During ablation procedure, in minutes)
  • Freedom from atrial fibrillation and other atrial arrhythmias in patients undergoing surgical AF ablation.(at 6 and 12 months)
  • ECGI calculations of Lowest Dominant Frecuency(Hz)(during ablation procedure and 12 months after)
  • ECGI calculations of Rotor duration from rotor maps(ms)(during ablation procedure and 12 months after)
  • ECGI calculations of simultaneus number of rotors from rotor maps(ms)(during ablation procedure and 12 months after)
  • Freedom from atrial fibrillation treated according to the ESC/AHA atrial fibrillation Guidelines evaluated in binary(0:AF Freedom;1:AF)(12 months post-first intervention)
  • Freedom from atrial fibrillation in patients undergoing rhythm control drug treatment.(at 6 and 12 months)
  • Electrophysiological characteristics of the Atrial fibrillation complexity(Inclusion, rhythm vs rate treatment, ablation)
  • Electroanatomic reconstruction and recordings of electrical activity(During ablation procedure)
  • Trained Neural Network based on ECGI signals(6 and 12 month post-ablation outcome prediction)

研究者

发起方
Felipe Atienza
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Felipe Atienza

Head of cardiovascualar research and training, Cardiology Department

Hospital General Universitario Gregorio Marañon

研究点 (1)

Loading locations...

相似试验